532 filings
Page 4 of 27
8-K
sy8jwfhq
23 Jun 21
Company Fully Prepared to Commence Phase 2b Trials of JAN101 for Peripheral Artery Disease (PAD) as Soon as New Protocol is Approved by the FDA
10:14am
8-K
0cmztc2wcz0n2vl6ui1
22 Jun 21
JanOne Selects Regulatory Partner for Phase 2b Trial as Investigational Plan is Prepared for FDA Filing
9:46am
8-K
0gykaq3ov1k5gy5 20c
15 Jun 21
JanOne Appoints Internationally Renowned Expert on Addiction Nicholas Goeders, Ph.D. to Scientific Advisory Board
10:16am
8-K
y2pupnyj0y8qvs4lteuy
8 Jun 21
Other Events
9:45am
8-K
f4cc7vkh ec6iei2ck4m
16 Apr 21
Amendments to Articles of Incorporation or Bylaws
5:00pm
S-8
biybg24f88
30 Mar 21
Registration of securities for employees
5:09pm
8-K
ace8bh3 0ul5uo2ac1p2
25 Feb 21
JanOne Announces Definitive Agreement to Sell its Legacy Recycling Business for $25 Million
4:05pm
8-K
2eskbn5m
2 Feb 21
JanOne Announces Closing of $6.0 Million Common Stock Offering
5:27pm
424B5
0k40c54 mq66
2 Feb 21
Prospectus supplement for primary offering
1:30pm
8-K
2co 5hucy0a
29 Jan 21
JanOne Prices $6.0 Million Common Stock Offering
9:08am
EFFECT
epdt3en 4m
30 Dec 20
Notice of effectiveness
12:15am
CORRESP
qeidumq7 u5d95e9e
29 Dec 20
Correspondence with SEC
12:00am
UPLOAD
cgbed79puprqjcue
28 Dec 20
Letter from SEC
12:00am
RW
k2q eb1d6o
19 Nov 20
Registration withdrawal request
5:00pm
8-K
dksr9po2
2 Oct 20
Amendments to Articles of Incorporation or Bylaws
12:00am